European Archives - Page 654 of 1002 - European Medical Journal

Continue
11 Oct 2018

Johnson & Johnson Vision Encourages Public to #spotlightsight for World Sight Day

Sight is arguably the most prized of all human senses. Yet, there are many people who do not fully experience the wonder of this gift.
11 Oct 2018

European Medical Journal Presents: EMJ Cardiology 6.1

The publication of EMJ Cardiology 6.1 is now available and features a full review of the European Society of Cardiology (ESC) 2018 Congress…
October 2018

EMJ Cardiology 6.1 2018

As well as capturing the event’s bustling atmosphere within the pages of its Congress Review, this year’s eJournal presents key research, discussion, and…
1 Mins
11 Oct 2018

Fibre-Optic Contact Force Catheter Efficiency and Effectiveness in Paroxysmal Atrial Fibrillation Ablation from a Large, Multinational, Prospective Registry (ABLATOR)

Over recent years, in response to the widespread use of contact force (CF) ablation catheters for the treatment of atrial fibrillation, numerous studies…
17 Mins
11 Oct 2018

Review of the European Society of Cardiology Congress 2018

Known as the largest cardiovascular conference in the world, it was apt that the high standards of the European Society of Cardiology (ESC) were matched…
10 Mins
11 Oct 2018

Guidelines, Clinical Evidence, and Real-Life Practice: How to Find Your Way in Managing Hypercholesterolaemia

Prof Masana presented evidence that low-density lipoprotein (LDL) cholesterol is a causal factor for atherosclerosis and that cardiovascular disease (CVD…
2 Mins
11 Oct 2018

Impact of a Cardiac Rehabilitation Programme After a Myocardial Infarction in Individuals Not Undergoing Revascularisation: New Horizons for a Time-Tested Intervention

Cardiac rehabilitation (CR) plays a pivotal role in the contemporary management of myocardial infarction (MI) patients and several studies have…
4 Mins
11 Oct 2018

Reversal of Apixaban and Rivaroxaban Anticoagulation by Andexanet Alfa in ANNEXA-A and ANNEXA-R as Assessed by Non-Tissue Factor-Initiated Thrombin Generation Independent of Tissue Factor Pathway Inhibitor

Andexanet alfa is a modified factor Xa (FXa) drug designed to bind and sequester FXa inhibitors and thus reverse anticoagulation…
2 Mins
11 Oct 2018

Congress Interview from the ESC Congress 2018

During the ESC 2018 Congress, we met with EMJ Cardiology’s Editor-in-Chief, Dr Çetin Erol, to ask about his experience of this year’s event and his…
10 Mins
11 Oct 2018

Editor’s Pick: Contemporary Use of Intracoronary Imaging in Percutaneous Coronary Intervention

For >50 years, coronary angiography has been the gold standard for the assessment of coronary anatomy; however, as an isolated technique to guide the…